Aurinia Pharmaceuticals, Inc. (AUPH)
15.80
+0.14
(+0.89%)
USD |
NASDAQ |
Jun 09, 16:00
15.80
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals SG&A Expense (Quarterly) : 22.03M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| enGene Therapeutics, Inc. | 8.93M |
| Medicus Pharma Ltd. | 4.296M |
| Kiniksa Pharmaceuticals International Plc | 61.15M |
| Xenon Pharmaceuticals, Inc. | 23.82M |
| Psyence Biomedical Ltd. | 0.2659M |